Chemify Unveils World's First Chemputation Facility in Glasgow, Pioneering the Future of Molecular Design
TL;DR
Chemify's Chemifarm offers partners a competitive edge by accelerating the discovery of small-molecule medicines and next-generation materials through AI-driven molecular design and robotic synthesis.
The Chemifarm integrates AI-driven molecular-design with industrial-scale robotic synthesis, utilizing the Chemputation platform to streamline the design, optimization, and scale-up of complex molecules.
Chemify's Chemifarm advances global health and materials science, creating jobs and fostering economic growth while tackling society's toughest challenges with innovative chemical solutions.
Discover how Chemify's Chemifarm, the world's most advanced automated chemistry facility, is revolutionizing molecular design and synthesis with AI and robotics in Glasgow.
Found this article helpful?
Share it with your network and spread the knowledge!
Chemify has officially launched the world's first Chemputation facility in Glasgow, Scotland, setting a new benchmark in molecular design and manufacture. This 21,500-ft² facility, known as Chemifarm, integrates AI-driven molecular design with industrial-scale robotic synthesis, significantly reducing the time from concept to compound. This development is poised to revolutionize the discovery of small-molecule medicines and next-generation materials, addressing some of society's most pressing challenges.
At the heart of Chemifarm is the Chemputation platform, a combination of a bespoke programming language, extensible robotics, and the world's largest library of validated reactions. This platform enables the design, optimization, and scale-up of molecules previously considered unreachable. Lee Cronin, CEO and Founder of Chemify, describes the facility as a watershed moment for molecular innovation, highlighting its potential to accelerate breakthroughs in drug discovery and materials science.
The £12 million project, supported by the Glasgow City Region Innovation Accelerator Programme and a £1.1M grant from Scottish Enterprise, is expected to create 60 new jobs and safeguard over 50 existing roles in Glasgow. The facility features dedicated production suites, R&D labs, and a secure cloud architecture for storing petabytes of chemical data, underscoring its role in advancing AI-powered chemical analysis.
Chemify's partners in the pharmaceutical, biotech, and materials-science sectors will benefit from confidential, on-demand access to bespoke molecules for research and development. The Chemifarm's capabilities in designing and testing chemical compounds will be instrumental in developing innovative solutions with specific properties.
This initiative not only positions Scotland at the forefront of the global healthtech market but also exemplifies the transformative impact of translating academic research into industrial innovation. With the backing of Innovate UK and Scottish Enterprise, Chemify's Chemifarm is a testament to the UK's leadership in advanced chemical and pharmaceutical industries, promising to deliver significant economic and scientific benefits.
Curated from Reportable
